论文部分内容阅读
目的:研究分析小儿肺炎患者接受阿奇霉素治疗的临床效果。方法:根据2013年1月至2014年1月该院的63例小儿支原体肺炎患儿进行研究分析,将这些患儿分成实验组和对照组,实验组32例患儿接受了阿奇霉素静脉注射治疗,对照组31例使用红霉素静滴治疗,对两组的临床治疗效果、体征改善、并发症等进行比较分析。结果:经过治疗后,实验组患者临床治疗有效率是96.88%,对照组的临床治疗有效率是74.19%,结果存在统计学差异性(P<0.05);实验组患儿的临床症状改善情况比对照组优秀,患儿症状消失时间和住院时间比对照组短(P<0.05);实验组不良反应发生率是9.38%,对照组是35.48%,结果存在统计学差异性(P<0.05)。结论:临床中小儿肺炎患者接受阿奇霉素治疗的效果,临床中症状改善,体征改善要比红霉素优秀,住院时间短,不良反应发生率低,安全性更高,所以我们推介临床中小儿肺炎患者选择该种治疗方式,临床中可以进行推广使用。
Objective: To study the clinical effect of azithromycin in children with pneumonia. Methods: According to the analysis of 63 children with mycoplasma pneumonia from January 2013 to January 2014 in our hospital, these children were divided into experimental group and control group. 32 cases of experimental group received azithromycin intravenous injection, Control group of 31 patients treated with erythromycin intravenous infusion, the clinical efficacy of the two groups, signs, complications and other comparative analysis. Results: After treatment, the effective rate of clinical treatment was 96.88% in the experimental group and 74.19% in the control group, with statistically significant difference (P <0.05). The clinical symptoms in the experimental group were better than those in the experimental group The control group was excellent, the disappearance time and hospitalization time of children were shorter than that of the control group (P <0.05). The incidence of adverse reactions was 9.38% in the experimental group and 35.48% in the control group. There was a statistically significant difference (P <0.05). Conclusion: The effect of azithromycin treatment in clinical children with pneumonia, clinical symptoms, signs better than erythromycin, shorter hospital stay, the incidence of adverse reactions, safety and higher, so we recommend clinical children with pneumonia Choose the kind of treatment, clinical use can be promoted.